| MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool H Gad, T Koolmeister, AS Jemth, S Eshtad, SA Jacques, CE Ström, ... Nature 508 (7495), 215-221, 2014 | 554 | 2014 |
| Validation and development of MTH1 inhibitors for treatment of cancer UW Berglund, K Sanjiv, H Gad, C Kalderen, T Koolmeister, T Pham, ... Annals of oncology 27 (12), 2275-2283, 2016 | 142 | 2016 |
| BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells TR Lunavat, L Cheng, BO Einarsdottir, R Olofsson Bagge, ... Proceedings of the National Academy of Sciences 114 (29), E5930-E5939, 2017 | 128 | 2017 |
| Molecular profiling of driver events in metastatic uveal melanoma J Karlsson, LM Nilsson, S Mitra, S Alsén, GV Shelke, VR Sah, ... Nature communications 11 (1), 1894, 2020 | 124 | 2020 |
| Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions BO Einarsdottir, RO Bagge, J Bhadury, H Jespersen, J Mattsson, ... Oncotarget 5 (20), 9609, 2014 | 72 | 2014 |
| MITF reprograms the extracellular matrix and focal adhesion in melanoma R Dilshat, V Fock, C Kenny, I Gerritsen, RMJ Lasseur, J Travnickova, ... Elife 10, e63093, 2021 | 56 | 2021 |
| Hip fractures and bone mineral density in the elderly—importance of serum 25-hydroxyvitamin D L Steingrimsdottir, TI Halldorsson, K Siggeirsdottir, MF Cotch, ... PloS one 9 (3), e91122, 2014 | 56 | 2014 |
| High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer I Reynisdottir, A Arason, BO Einarsdottir, H Gunnarsson, J Staaf, ... Cancer medicine 2 (4), 437-446, 2013 | 44 | 2013 |
| A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma BO Einarsdottir, J Karlsson, EMV Söderberg, MF Lindberg, ... Cell Death & Disease 9 (8), 810, 2018 | 40 | 2018 |
| BET bromodomain inhibitors synergize with ATR inhibitors in melanoma SV Muralidharan, BO Einarsdottir, J Bhadury, MF Lindberg, J Wu, ... Cell death & disease 8 (8), e2982-e2982, 2017 | 20 | 2017 |
| Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms T Zhang, J Choi, R Dilshat, BÓ Einarsdóttir, MA Kovacs, M Xu, M Malasky, ... The American Journal of Human Genetics 108 (9), 1631-1646, 2021 | 12 | 2021 |
| Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts J Bhadury, BO Einarsdottir, A Podraza, RO Bagge, U Stierner, L Ny, ... Oncotarget 7 (17), 23801, 2016 | 12 | 2016 |
| Mutational signature and transcriptomic classification analyses as the decisive diagnostic tools for a cancer of unknown primary RO Bagge, A Demir, J Karlsson, B Alaei-Mahabadi, BO Einarsdottir, ... JCO precision oncology 2, 1-25, 2018 | 11 | 2018 |
| Correction: Corrigendum: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool H Gad, T Koolmeister, AS Jemth, S Eshtad, SA Jacques, CE Ström, ... Nature 544 (7651), 508-508, 2017 | 5 | 2017 |
| Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanoma J Karlsson, LM Nilsson, EMV Forsberg, S Mitra, S Alsén, G Shelke, ... bioRxiv, 742023, 2019 | 4 | 2019 |
| MITF reprograms the extracellular matrix and focal adhesion in melanoma D Ramile, V Fock, C Kenny, G Ilse, LRM Jacques, T Jana, C Philipp, ... eLife 10, 2021 | 1 | 2021 |
| Abstract B38: Melanoma patient-derived xenografts accurately models the disease and develop fast enough to guide treatment decisions BO Einarsdottir, RO Bagge, J Bhadury, H Jespersen, LM Nilsson, ... Cancer Research 75 (14_Supplement), B38-B38, 2015 | 1 | 2015 |
| Long-term use of rituximab increases T cell count in MS patients GS Björnsson, H Sigurgrímsdóttir, SM Maggadóttir, BÓ Einarsdóttir, ... Frontiers in Immunology 15, 1412668, 2024 | | 2024 |
| MITF Isoforms-Insights from an RNA-Seq study K Kirty, S Sigurðsson, Þ Guðjónsson, B Ósk Einarsdóttir, S Sigurðsson bioRxiv, 2020.10. 22.351031, 2020 | | 2020 |
| A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma (vol 9, 810, 2018) BO Einarsdottir, J Karlsson, E Soderberg, MF Lindberg, E Funck-Brentano, ... CELL DEATH & DISEASE 11 (2), 2020 | | 2020 |
